|
|
||||||||
1 Department of Internal Medicine, School of Medicine, 3 Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California at Davis, Davis 95616; and 2 Department of Pharmacology, Berlex Biosciences, Richmond, California 94804
Cardiovascular diseases, such
as atherosclerosis and hypertension, are associated with arterial
stiffening. Previous studies showed that ANG II exacerbated
atherosclerosis and induced hypertension and aneurysm formation in
apolipoprotein E-deficient (apoE-KO) mice. The aim of the present study
was to examine the effects of chronic treatment of ANG II on the
arterial elastic properties in apoE-KO mice. We hypothesized that ANG
II will injure the arterial wall resulting in increased arterial
stiffening. Male apoE-KO mice were infused with either ANG II (1.44 mg · kg
1 · day
1) or vehicle
(PBS) for 30 days. ANG II treatment accelerated atherosclerosis in the carotid artery by sixfold (P < 0.001) and
increased blood pressure by 30% (P < 0.05).
Additionally, our data demonstrated that ANG II increased arterial
stiffening using both in vivo and in vitro methods. ANG II
significantly increased pulse wave velocity by 36% (P < 0.01) and decreased arterial elasticity as demonstrated by a more
than 900% increase in maximal stiffening (high strain Young's
modulus) compared with vehicle (P < 0.05). These
functional changes were correlated with morphological and biochemical
changes as demonstrated by an increase in collagen content (60%), a
decrease in elastin content (74%), and breaks in the internal elastic
lamina in the aortic wall. In addition, endothelium-independent
vasorelaxation to sodium nitroprusside was impaired in the aortic rings
of ANG II-treated mice compared with vehicle. Thus, the present data indicate that ANG II injures the artery wall in multiple ways and
arterial stiffening may be a common outcome of ANG II-induced arterial damage.
aneurysm; atherosclerosis; hypertension; vascular stiffness
This article has been cited by other articles:
![]() |
A. E. Mullick, U. B. Zaid, C. N. Athanassious, S. R. Lentz, J. C. Rutledge, and J. D. Symons Hyperhomocysteinemia increases arterial permeability and stiffness in mice Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1349 - R1354. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Fitch, J. C. Rutledge, Y.-X. Wang, A. F. Powers, J.-L. Tseng, T. Clary, and G. M. Rubanyi Synergistic effect of angiotensin II and nitric oxide synthase inhibitor in increasing aortic stiffness in mice Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1190 - H1198. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M.P. Arruda, V. A. Peotta, S. S. Meyrelles, and E. C. Vasquez Evaluation of Vascular Function in Apolipoprotein E Knockout Mice With Angiotensin-Dependent Renovascular Hypertension Hypertension, October 1, 2005; 46(4): 932 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Xiao, S. Fuchs, K. Frenzel, J. M. Cole, and K. E. Bernstein Newer Approaches to Genetic Modeling in Mice: Tissue-Specific Protein Expression as Studied Using Angiotensin-Converting Enzyme (ACE) Am. J. Pathol., September 1, 2003; 163(3): 807 - 817. [Full Text] [PDF] |
||||
![]() |
K. Saraff, F. Babamusta, L. A. Cassis, and A. Daugherty Aortic Dissection Precedes Formation of Aneurysms and Atherosclerosis in Angiotensin II-Infused, Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1621 - 1626. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |